Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Cytomegalovirus Infection

Free Subscription Articles published in Antimicrob Agents Chemother Retrieve available abstracts of 18 articles: HTML format Text format

Single Articles

April 2018
1. OIKNINE-DJIAN E, Weisblum Y, Panet A, Wong HN, et al
   The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication.
   Antimicrob Agents Chemother. 2018 Apr 30. pii: AAC.00288.
   PubMed     Text format     Abstract available
   
   
   March 2018
2. DONG Q, Leroux S, Shi HY, Xu HY, et al
   Model-based Dosage Individualization of Ganciclovir in Neonates and Young Infants with Congenital Cytomegalovirus Infection: A Pilot Study.
   Antimicrob Agents Chemother. 2018 Mar 5. pii: AAC.00075.
   PubMed     Text format     Abstract available
   
   
   November 2017
3. DENG R, Wang Y, Maia M, Burgess T, et al
   Pharmacokinetics and exposure-response analysis of RG7667, a combination of two anti-cytomegalovirus monoclonal antibodies, in a Phase 2a randomized trial to prevent cytomegalovirus infection in high-risk kidney transplant recipients.
   Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01108.
   PubMed     Text format     Abstract available
   
   
   October 2017
4. MENG W, Tang A, Ye X, Gui X, et al
   Targeting Human Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-gB Bispecific Antibody.
   Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01719.
   PubMed     Text format     Abstract available
   
   
   August 2017
5. CHOU S
   Comparison of Cytomegalovirus Terminase Gene Mutations Selected after Exposure to Three Distinct Inhibitor Compounds.
   Antimicrob Agents Chemother. 2017 Aug 21. pii: AAC.01325.
   PubMed     Text format     Abstract available
   
   
   
6. PIRET J, Goyette N, Boivin G
   Drug Susceptibility and Replicative Capacity of Multi-Drug Resistant Recombinant Human Cytomegalovirus Harboring Mutations in UL56 and UL54 Genes.
   Antimicrob Agents Chemother. 2017 Aug 14. pii: AAC.01044.
   PubMed     Text format     Abstract available
   
   
   November 2016
7. ISHIDA JH, Patel A, Mehta AK, Gatault P, et al
   Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.
   Antimicrob Agents Chemother. 2016 Nov 21. pii: AAC.01794.
   PubMed     Text format     Abstract available
   
   
   June 2016
8. PATEL HD, Nikitin P, Gesner T, Lin JJ, et al
   In vitro characterization of human cytomegalovirus-targeting therapeutic monoclonal antibodies LJP538 and LJP539.
   Antimicrob Agents Chemother. 2016 Jun 6. pii: AAC.00382.
   PubMed     Text format     Abstract available
   
   
   May 2016
9. CHEN H, Li C, Zemlicka J, Gentry BG, et al
   Potency and Stereoselectivity of Cyclopropavir Triphosphate Action on Human Cytomegalovirus DNA Polymerase.
   Antimicrob Agents Chemother. 2016 May 2. pii: AAC.00449.
   PubMed     Text format     Abstract available
   
   
   April 2016
10. CHOU S, Ercolani RJ, Lanier ER
    Novel Cytomegalovirus UL54 DNA Polymerase Gene Mutations Selected in Vitro that Confer Brincidofovir Resistance.
    Antimicrob Agents Chemother. 2016 Apr 4. pii: AAC.00214.
    PubMed     Text format     Abstract available
    
    
    
11. PADULLES A, Colom H, Bestard O, Melilli E, et al
    Contribution of Population Pharmacokinetics to Dose Optimization of Ganciclovir-Valganciclovir in Solid-Organ Transplant Patients.
    Antimicrob Agents Chemother. 2016;60:1992-2002.
    PubMed     Text format     Abstract available
    
    
    February 2016
12. DOLE K, Segal FP, Feire A, Magnusson B, et al
    A first-in-human study to assess the safety and pharmacokinetics of monoclonal antibodies against human cytomegalovirus in healthy volunteers.
    Antimicrob Agents Chemother. 2016 Feb 29. pii: AAC.02698.
    PubMed     Text format     Abstract available
    
    
    November 2015
13. VAZQUEZ JA, Manavathu EK
    Molecular Characterization of a Voriconazole-resistant, Posaconazole-susceptible, Aspergillus fumigatus Isolate in a Lung Transplant Recipient in the United States.
    Antimicrob Agents Chemother. 2015 Nov 16. pii: AAC.01130.
    PubMed     Text format     Abstract available
    
    
    August 2015
14. CHOU S
    Rapid in Vitro Evolution of Human Cytomegalovirus UL56 Mutations that Confer Letermovir Resistance.
    Antimicrob Agents Chemother. 2015 Aug 10. pii: AAC.01623.
    PubMed     Text format     Abstract available
    
    
    June 2015
15. ISHIDA JH, Burgess T, Derby M, Brown PA, et al
    Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anti-Cytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults.
    Antimicrob Agents Chemother. 2015 Jun 8. pii: AAC.00523.
    PubMed     Text format     Abstract available
    
    
    April 2015
16. HUTTERER C, Eickhoff J, Milbradt J, Korn K, et al
    A novel CDK7 inhibitor of the Pyrazolotriazine class exerts broad-spectrum antiviral activity at nanomolar concentrations.
    Antimicrob Agents Chemother. 2015;59:2062-71.
    PubMed     Text format     Abstract available
    
    
    October 2014
17. DONALISIO M, Ranucci E, Cagno V, Civra A, et al
    Agmatine-containing poly(amidoamine)s as a novel class of antiviral macromolecules: structural properties and in vitro evaluation of infectivity inhibition.
    Antimicrob Agents Chemother. 2014;58:6315-9.
    PubMed     Text format     Abstract available
    
    
    September 2014
18. TAVIS JE, Wang H, Tollefson AE, Ying B, et al
    Inhibitors of nucleotidyl transferase superfamily enzymes suppress herpes simplex virus replication.
    Antimicrob Agents Chemother. 2014 Sep 29. pii: AAC.03875.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: